& Krohne, G
Experts believe that for heart failure and diabetic kidney disease, SGLT2is should come first
Now, there are sugar-free varietiesor, you could go straight to the source
In the action in diabetes and vascular disease (ADVANCE) trial, a study involving 11,140 subjects with T2DM who were followed for a median duration of 4.4 years, a higher HR was associated with a significantly increased risk of all-cause mortality, cardiovascular death, and major cardiovascular events (death, nonfatal acute myocardial infarction [AMI] or nonfatal stroke) [39]
Local, Face-to-Face Care When you have questions or concerns, youre not submitting a support ticket
Khabbazi T., Mahdavi R., Safa J., Pour-Abdollahi P